Stent update-2017.

• IMA recommends an everolimus-eluting stent (EES), either with a durable or bioresorbable polymer or Resolute zotarolimus-eluting stent (R-ZES).
• Any stent approved by DCGI is good. The responsibility is on the DCGI and the expert committee under Technical Drug Advisory Board (DTAB). 

• The DCGI also has a PvPi program (9717776514 phone number). If the department receives any report of side effects of any device, the device can be immediately taken off the market. 
• Till today, the very fact that Indian stents can be marketed means no adverse effects have been notified to PvPI so far.